Concepedia

Ornella Pagliano

OP

Statistics

Publications

13

Citations

3.7K

H-Index

12

Active since

2009

Affiliations

University of Pittsburgh(Current)

UPMC Hillman Cancer Center

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Brigham and Women's Hospital

Ornella Pagliano is an author at University of Pittsburgh specializing in oncology, immunology, and cancer immunotherapy.

Publications per year

2009–2024

13

Publications

13

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

Diwakar Davar, Amiran Dzutsev, John A. McCulloch et al. · Science · 2021 · 1.6K citations · Full text

Life Sciences, Immunology, Oncology +17

TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients

Joë-Marc Chauvin, Ornella Pagliano, Julien Fourcade et al. · Journal of Clinical Investigation · 2015 · 769 citations · Full text

Life Sciences, Immunology, Oncology +17

CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

Julien Fourcade, Zhaojun Sun, Ornella Pagliano et al. · Cancer Research · 2011 · 366 citations · Full text

Life Sciences, Immunology, Oncology +17

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines

Julien Fourcade, Zhaojun Sun, Ornella Pagliano et al. · Cancer Research · 2013 · 205 citations · Full text

Medicine, Immunology, Oncology +17

CD226 opposes TIGIT to disrupt Tregs in melanoma

Julien Fourcade, Zhaojun Sun, Joë-Marc Chauvin et al. · JCI Insight · 2018 · 200 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 13